Physician profile
Michael Greene
NPI 1912295502
$685.27
in general payments reported to CMS, 2019-2025
16 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.66 · 2021: $55.73 · 2022: $40.91 · 2023: $170 · 2024: $229 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $550.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $149.82 | 2019-2024 | |
| Inari Medical, INC. | $103.36 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $99.84 | 2023-2024 | |
| Abiomed | $76.87 | 2024-2025 | Impella |
| Stryker Corporation | $56.85 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbvie INC. | $28.46 | 2021 | |
| Daiichi Sankyo INC. | $25.90 | 2022 | |
| Merck Sharp & Dohme LLC | $21.12 | 2024 | Zerbaxa, Dificid, Recarbrio |
| Recor Medical INC | $20.81 | 2024 | Paradise Renal Denervation System |
| Atricure, INC. | $18.77 | 2023 | |
| Boston Scientific Corporation | $17.74 | 2024 | Watchman Flx |
| Inspire Medical Systems, INC. | $17.16 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $14.72 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.55 | 2019 | |
| Melinta Therapeutics, LLC | $11.30 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivaquant INC, Dba Rhythm Express | $10.00 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.